Sales of a drug that a Mallinckrodt PLC unit bought the rights for prior to its 2020 Chapter 11 bankruptcy should still trigger an obligation to pay the drug's originator royalties, since the deal allegedly survived the reorganization, an attorney for Sanofi Aventis told the Third Circuit on Monday.
The main thing Christopher Warman Sr. added to a veteran chocolatier's recipe to make his "chocolate moonshine" fudge was salesmanship and he failed to change enough or protect the recipe enough for it to qualify as a trade secret, counsel for his ex-wife and two other businesses argued Thursday at the close of a federal trial in Pennsylvania.
A cryptocurrency influencer and owner of a Pittsburgh-based AI app company said his former chief investment officer faked his bona fides as an attorney and pilot when enticing him to buy a Colorado prisoner-transport company, then backed out of the business and sabotaged its prospects, according to a lawsuit filed in Pennsylvania state court.
A Pennsylvania state court judge asked a federal court to pass on the civil rights suit an attorney filed against him after being jailed for contempt of court, arguing that a state appellate court could handle the lawyer's concerns and there was no chance that the original contempt would land him back in jail.
Judges on a Third Circuit panel were skeptical Wednesday of arguments from AbbVie Inc. that a lower court's ruling on discovery of attorney communications in a "sham" patent case would open the floodgates to privilege challenges any time a drug company files a suit that slows down a competitor.